AUXILIUM PHARMACEUT (NASDAQ:AUXL)
30.97
-0 (-0%)
| AUXILIUM PHARMACEUT (NASDAQ:AUXL) Delayed : |
| Previous Close |
$30.97 |
|
52 Week High |
$37.28 |
|
| Open |
$31.27 |
|
52 Week Low |
$21.85 |
| Day High |
$31.40 |
|
P/E |
N/A |
| Day Low |
$30.67 |
|
EPS |
$-1.27 |
| Volume |
950,869 |
|
|
|
| More AUXL Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on AUXL
-
Feb 3, 2010 10:19 AM
Morning Movers 2/3: HDIX, BGP, APKT, TDSC, CGX, NETL Higher; XIDE, VSR, PLNR, R, CNLG Lower
-
Feb 3, 2010 06:47 AM
Auxilium (AUXL) Announces FDA Approval for XIAFLEX
-
Jan 21, 2010 07:48 AM
Pfizer (PFE) and Auxilium Pharma (AUXL) Receives OK from EMA to Market XIAFLEX in Europe
-
Jan 11, 2010 10:57 AM
Auxilium Pharma (AUXL) Guides FY09 Inline with the Street
-
Dec 17, 2009 10:51 AM
Notable Analyst Rating Changes 12/17: NWSA, UNM, LNC, PTV Upgraded; ADP, AEM, FGXI, OC Downgrades
View All Reports
StreetInsider Reports on AUXL by Category
-
Jan 17, 2010 04:00 AM
Healthcare Conference Updates: Cytori, Auxilium, Keryx, Cell Therapeutics
-
Oct 28, 2009 05:59 PM
Auxilium Pharmaceuticals, Inc. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
-
Oct 14, 2009 07:24 AM
Auxilium Inches Toward FDA Approval for Xiaflex
-
Sep 14, 2009 04:13 PM
Monday's Options Recap
-
Aug 20, 2009 12:38 PM
Thursday Options Update: LVS, AIG, HD & AUXL
View All Blogs
Comments on AUXL
No comments are currently available.
on Dec 1, 2009
at 04:13 PM ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
on Nov 25, 2009
at 03:06 PM xiaflex xiaflex has a much stronger upward potential than indicated. xiaflex can and will probably be used off label for peyronie's, frozen shoulder, as well as scarring for burn survivors as well as post surgical wounds. Once available to the physician the injectable collagenase will be used by many sub specialties of surgery as well as other specialty groups Auxilium is worth over $50.00 per share, and the supplier of the collagenase, BSTC, is also worth $50.00 per share
Article: Bank of America Resumes Coverage on Auxilium Pharmaceuticals (AUXL) with a Buy
on Sep 9, 2009
at 09:41 PM XIAFLEX(TM)for duentren's I am interested in information on this new treatment
Article: Auxilium Pharmaceuticals (AUXL) XIAFLEX for the Treatment of Dupuytren's Contracture Receives Priority Review From the FDA
on Jun 23, 2009
at 07:24 PM xiaflex THE OFF LABEL INDICATIONS FOR A COLLAGENASE BASED INJECTIBLE FOR BURN SCARS, POST SURGICAL SCARS, KELOIDS, AS WELL AS OTHER INDICATIONS WOULD GREATLY EXPAND THE USE OF XIAFLEX.
Article: Hapoalim Securities Initiates Coverage on BioSpecifics (BSTC) with a Market Outperform; Possible Acquisition Play
on Jun 11, 2009
at 03:53 PM Breen I am interested in knowing when you think this drug will be available to patients. Thanks
Article: Auxilium Pharmaceuticals (AUXL) XIAFLEX for the Treatment of Dupuytren's Contracture Receives Priority Review From the FDA